Literature DB >> 27091335

Does securin expression have significance in prognostication of oral tongue cancer? A pilot study.

Ilkka Heikkinen1,2, Alhadi Almangush1,2,3, Jaana Hagström1,4, Ibrahim O Bello5, Joonas H Kauppila6,7, Laura K Mäkinen8, Caj Haglund4,9, Pentti Nieminen10, Tuula Salo2,11,12,13, Ilmo Leivo14,15.   

Abstract

The proliferation marker, securin, is involved in the progression of many carcinomas. However, its expression in oral tongue squamous cell carcinoma (OTSCC) has not been previously studied. We examined securin expression by immunohistochemistry in OTSCC. A total of 93 cases treated for OTSCC were included in this study. Expression of securin in OTSCC was studied by immunohistochemistry of tissue microarrays (52 cases) and routine tumor sections (41 cases). Securin overexpression is significantly associated with higher tumor grade (P = 0.03). Overexpression of securin was observed more frequently in advanced stages of OTSCC than in earlier stages but the difference was not statistically significant. These findings suggest that overexpression of securin in OTSCC may be important during progression of this cancer. No significant association was found between securin expression and the prognosis of OTSCC.

Entities:  

Keywords:  Expression; Oral tongue squamous cell carcinoma; Prognosis; Securin

Mesh:

Substances:

Year:  2016        PMID: 27091335     DOI: 10.1007/s00405-016-3964-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  24 in total

1.  Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.

Authors:  Tsutomu Fujii; Shuji Nomoto; Katsumi Koshikawa; Yasushi Yatabe; Osamu Teshigawara; Toshiaki Mori; Soichiro Inoue; Shin Takeda; Akimasa Nakao
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

2.  Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis.

Authors:  R Yu; A P Heaney; W Lu; J Chen; S Melmed
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

3.  Association of pituitary tumor transforming gene expression with early oral tumorigenesis and malignant progression of precancerous lesions.

Authors:  Li-Jen Liao; Yi-Hsin Hsu; Chuan-Hang Yu; Chun-Pin Chiang; Jing-Ru Jhan; Lien-Cheng Chang; Jing-Jer Lin; Pei-Jen Lou
Journal:  Head Neck       Date:  2010-11-10       Impact factor: 3.147

Review 4.  Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I).

Authors:  Ibrahim O Bello; Ylermi Soini; Tuula Salo
Journal:  Oral Oncol       Date:  2010-07-15       Impact factor: 5.337

5.  Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases.

Authors:  P C Rodrigues; M C C Miguel; E Bagordakis; F P Fonseca; S N de Aquino; A R Santos-Silva; M A Lopes; E Graner; T Salo; L P Kowalski; R D Coletta
Journal:  Int J Oral Maxillofac Surg       Date:  2014-02-28       Impact factor: 2.789

6.  High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.

Authors:  Inês M B Moura; Maria L Delgado; Patrícia M A Silva; Carlos A Lopes; José B do Amaral; Luís S Monteiro; Hassan Bousbaa
Journal:  J Oral Pathol Med       Date:  2013-09-16       Impact factor: 4.253

7.  PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target.

Authors:  Michael J Demeure; Kathryn E Coan; Clive S Grant; Richard A Komorowski; Elizabeth Stephan; Shripad Sinari; David Mount; Kimberly J Bussey
Journal:  Surgery       Date:  2013-12       Impact factor: 3.982

8.  Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer.

Authors:  Yasuyuki Shibata; Nobuhiro Haruki; Yoshiyuki Kuwabara; Tadashi Nishiwaki; Joji Kato; Noriyuki Shinoda; Atsushi Sato; Masahiro Kimura; Hiroshi Koyama; Tatsuya Toyama; Hideyuki Ishiguro; Junzo Kudo; Yukio Terashita; Shigeru Konishi; Yoshitaka Fujii
Journal:  Jpn J Clin Oncol       Date:  2002-07       Impact factor: 3.019

9.  Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer.

Authors:  K Talvinen; J Tuikkala; O Nevalainen; A Rantanen; P Hirsimäki; J Sundström; P Kronqvist
Journal:  Br J Cancer       Date:  2008-07-01       Impact factor: 7.640

10.  Cdc20 and securin overexpression predict short-term breast cancer survival.

Authors:  H Karra; H Repo; I Ahonen; E Löyttyniemi; R Pitkänen; M Lintunen; T Kuopio; M Söderström; P Kronqvist
Journal:  Br J Cancer       Date:  2014-05-22       Impact factor: 7.640

View more
  1 in total

1.  Clinical significance of securin expression in solid cancers: A PRISMA-compliant meta-analysis of published studies and bioinformatics analysis based on TCGA dataset.

Authors:  Xiang Liu; Wei Zeng; Dayang Zheng; Min Tang; Wangyan Zhou
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.